Pharmeasy API Holdings Ltd

Pharmeasy API Holdings Ltd
8
₹0.0
1(Y)
Share Price Chart
Pharmeasy API Holdings Ltd
8
  • Something bad
You'll receive a Whatsapp shortly for the next steps
Oops! Something went wrong while submitting the form.
Pharmeasy API Holdings Ltd
* Best In Industry
  • Something bad
You'll receive a Whatsapp shortly for the next steps
Oops! Something went wrong while submitting the form.
About Share

API Holdings Limited, commonly known as PharmEasy, is India's largest digital healthcare platform, primarily involved in the trading of pharmaceutical and cosmetic goods, as well as providing various healthcare services. The company was incorporated on March 31, 2019, and has since evolved into a comprehensive digital healthcare ecosystem.

Fundamentals
Pharmeasy API Holdings Ltd
8
Lot Size
₹1000.0
52 Week High
13
52 Week Low
13
Depository
NSDL&CDSL
PAN Number
AASCA1201E
ISIN Number
INE0DJ201029
CIN
U60100MH2019PLC323444
RTA
-
Market Cap (in cr)
541114
P/E Ratio
-₹96.6
P/B Ratio
1.14
Debt to Equity
-
ROE (%)
-
Book Value
7.7
Face Value
₹1.0
Valuation (In Cr)
Total Shares
6142041070
Financials (In Cr)
P&L Statement2021202220232024
Revenue269,056216,159269,056269,056
Cost of Material Consumed----
Gross Margins----
Change in Inventory----
Employee Benefit Expenses36,83932,61436,83936,839
Other Expenses28,97624,63428,97628,976
EBITDA----
OPM----
Other Income15,29010,92915,29015,290
Finance Cost771525771771
D&A3,7003,3843,7003,700
EBIT----
EBIT Margins----
PBT----
PBT Margins----
Tax (2021)55,07443,86655,07455,074
PAT----
NPM----
EPS----
Financial Ratios2021202220232024
Operating Profit Margin73.9272.7573.78-
Net Profit Margin11.3312.5714.71-
Earning Per Share (Diluted)62.8770.1268.44-
Assets2021202220232024
Fixed Assets218.57226.26233.37-
CWIP----
Investments664,542.06460,912.584768.45-
Trade Receivables10,769.595,655.30--
Inventory----
Other Assets----
Total Assets675,530.22466,794.145001.82-
Liabilities2021202220232024
Share Capital5058.235032.14--
FV----
Reserves669716.51470106.34--
Borrowings----
Trade Payables----
Other Liabilities----
Total Liabilities----
Cash-Flow Statement2021202220232024
PBT----
OPBWC--159,792.66201,641.89
Change in Receivables----
Change in Inventories----
Change in Payables----
Other Changes----
Working Capital Change----
Cash Generated From Operations--119,927.82143,842.72
Tax-43,715.7852,973.69-
Cash Flow From Operations-76,212.0466,869.03-
Purchase of PPE-852.93-901.85-97,339.23-130,489.03
Sale of PPE----
Cash Flow From Investment-852.93-901.85-97,339.23-130,489.03
Borrowing----
Divided-20,232.90-17,612.49--
Equity10,074.971,360.02--
Others From Financing-67.7-4,150.60--
Cash Flow from Financing-22,798.96-13,185.95--
Net Cash Generated-210.37-167.74-210.37-
Cash at the Start----
Cash at the End----
NSE India Unlisted Share
₹ 6200
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Create Alert
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Shareholding Pattern
Shareholding Pattern2021202220232024
Foreign Holding37%37%37%37%
Others63%63%63%63%
NSE India Unlisted Share
₹ 6200
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Create Alert
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Peer Ratio
Particulars (cr)
Revenue (FY23)
EPS (FY23)
Mcap (06.01.24)
P/E (06.01.24)
NSE India Unlisted Share
₹ 6200
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Create Alert
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Events
Name
Date
Details
IPO Withdrawal
45352
API Holdings withdrew its Initial Public Offering (IPO) citing "market conditions and external factors." This decision came after the company recorded a larger loss for FY22 compared to the previous year
Acquisition of Thyrocare
44440
API Holdings acquired Thyrocare, becoming the largest diagnostic test provider by volume in India. This acquisition expanded its portfolio significantly in the healthcare market
NSE India Unlisted Share
₹ 6200
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Create Alert
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Promoters or Management
Name
Designation
Experience
Linkedin Profile
Siddharth Shah
Managing Director and CEO
Aditya Puri
Chairman, Non-Executive Director
Dharmil Sheth
Whole-time Director
NSE India Unlisted Share
₹ 6200
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Create Alert
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

FAQ's

What are unlisted shares?
Unlisted shares are shares of a company that are not listed on any recognized stock exchange. They are usually traded privately or through over-the-counter (OTC) markets, offering investors an opportunity to invest in companies before they go public.
Are unlisted shares safe to invest in?
Like any investment, unlisted shares carry risks, including lower liquidity and lack of regulatory oversight compared to listed stocks. However, they can offer higher growth potential as you invest in companies before they go public. It's important to conduct thorough research or consult with a financial advisor before investing.
What are the tax implications of buying and selling unlisted shares?
Gains from unlisted shares are subject to capital gains tax in India. Short-term capital gains (if held for less than 24 months) are taxed at your applicable income tax rate, while long-term capital gains (if held for more than 24 months) are taxed at 20% with indexation benefits. Always consult a tax advisor for precise tax implications.
What is the difference between unlisted and listed shares?
Listed shares are traded on stock exchanges and are subject to strict regulatory oversight, which offers transparency and liquidity. Unlisted shares, on the other hand, are traded privately and may have limited information available, with lower liquidity but potentially higher growth prospects for early-stage investors.
How do I value unlisted shares?
Valuing unlisted shares can be complex since they are not publicly traded. The valuation typically depends on factors like the company's financials, growth potential, recent fundraising, and market conditions. It’s advisable to work with financial experts or brokers experienced in unlisted shares to get an accurate assessment.

Our Blogs

Learn More about unlisted shares

The Benefits of Investing in Unlisted Shares

When it comes to investing, most people focus on publicly listed companies. However, there's a growing interest in unlisted shares, which offer unique advantages for savvy investors.......

Why Pre-IPO Shares Could Be Your Next Big Investment Opportunity

As an investor, you're always looking for ways to maximize your returns while diversifying your portfolio.......

How to Evaluate the Value of Unlisted Shares Before Investing

Investing in unlisted shares can be highly rewarding, but it also requires a different approach compared ..........